Precision medicine immunotherapy for the treatment of neurodegeneration in herv-K-positive patients with amyotrophic lateral sclerosis
Ended Project Grant Awarded Last action
- Award ID
- HT94252310564
- Recipient
-
Formation Venture Engineering Foundry Inc. UEI TGUCUJNHUJA5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $734,781
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Topsfield, MA 01983, USA
Award details come from USAspending.gov.
About this award
This Project Grant from the Defense Health Agency provides $734,781 to Formation Venture Engineering Foundry Inc. for precision medicine immunotherapy research under the Military Medical Research and Development program (CFDA 12.420). The research aims to develop medical solutions for treating neurodegeneration in amyotrophic lateral sclerosis patients who test positive for human endogenous retrovirus K. The awardee will conduct applied and advanced biomedical research from June 2023 through June 2025 in Topsfield, Massachusetts to transform healthcare and investigate medical battlefield solutions, as outlined under the program. The funding supports investigating immunotherapies tailored to an individual's genetics, biology and proteomics for neurodegenerative conditions impacting military service members and the general public.
Quick answers
Who received award HT94252310564?
HT94252310564 was awarded to Formation Venture Engineering Foundry Inc. by Defense Health Agency (Department of Defense) on June 15, 2023.
How much is award HT94252310564 worth?
$734,781 has been obligated on HT94252310564.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award